How can the physician contribute to improving the quality of antibiotic use?;En quoi le clinicien contribue-t-il à l'amélioration de la qualité de l'antibiothérapie?

Medecine et Maladies Infectieuses

Volumn 33, Issue SUPPL. 1, 2003, Pages

  Garo, B ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Antibiotic policy; Antibiotic therapy

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CONFERENCE PAPER; COUNSELING; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EDUCATION PROGRAM; HOSPITAL; HUMAN; MEDICAL AUDIT; MEDICAL EDUCATION; MICROBIOLOGY; PHARMACIST; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; QUALITY CONTROL; VALIDATION PROCESS;

EID: 0037221202     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (95)

1. Kunin CM. Problems of antibiotic usage. Definitions, causes and proposed solutions. Ann Int Med 1978;89:802-5.
2. Craig W, Uman S, Shaw W. Hospital use of antimicrobial drugs. Survey at 19 hospitals and results of antimicrobial control programm. Ann Intern Med 1978;89:793-5.
3. Kunin CM, Chambers ST. Responsability of the infectious disease community for optimal use of antibiotics. Views of the membership of the Infectious Diseases Society of America. Rev Infect Dis 1985;7:547-59.
4. Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals. A statement by the Infectious Diseases Society of America. J Infect Dis 1988;157:869-76.
5. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996;275:234-40.
6. Andem. Le bon usage des antibiotiques à l'hôpital. Recommandations pour maîtriser le développement de la résistance bactérienne. Paris, 1996.
7. Shlaes D, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the prevention of antimicrobial resistance: Guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997;25:584-99.
8. Crémieux AC, Chastang C, Bernard L, Gallula P, Régnier B, Carbon C. L'utilisation des antibiotiques dans les hôpitaux est-elle appropriée? Journée de pharmacologie clinique. Journée de l'hôpital Claude Bernard. Du bon usage des antibiotiques à l'hôpital. Paris: Arnette Blackwell; 1996. p. 171-85.
9. Germaud P, Vuittenez F, Garo B, Chevalier A, Choutet P, Regnier B. Prescription des bêta-lactamines pour infections bronchopulmonaires communautaires de l'adulte. Observatoire en milieu hospitalier. Presse Med 2000;29:1159-65.
10. Gindre I, Maisonneuve H, Riche B, Durocher A. Le bon usage des antibiotiques à l'hôpital. État des lieux dans 207 établissements de santé publics et privés en. Presse Med 2000;29:1807-12.
11. d ed. New York: Churchill Livingstone; 1990. p. 427-34.
12. Avorn J, Harvey K, Soumeraï SB, Herxheimer A, Plumridge R, Bardelay G. Information and education as determinants of antibiotic use: Report of task force 5. Rev Infect Dis 1987;9(Suppl 3):286-96.
13. Sturm AW. Rational use of antimicrobial agents and diagnostic microbiology facilities. J Antimicrob Chemother 1988;22:257-60.
14. Dunagan WC, Woodward R, Medoff G, Grayl JL, Casabar E, Lawrenz C, et al. Antibiotic misuse in two clinical situations: Positive blood culture and administration of aminoglycosides. Rev Infect Dis 1991;13:405-12.
15. Burke JP. Antibiotic resistance, Squeezing the balloon? JAMA 1998;280:1270-1.
16. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998;244:379-86.
17. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-74.
18. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118:146-55.
19. Avorn J, Solomon DH. Cultural and economic factors that (mis) shape antibiotic use: The non pharmacologic basis of therapeutics. Ann Intern Med 2000;133:128-35.
20. Halm EA, Atlas SJ, Borowsky LH, Benzer TI, Metlay JP, Chang YC, et al. Understanding physician adherence with a pneumonia practice guideline: effects of patient, system, and physician factors. Arch Intern Med 2000;160:98-104.
21. Kollef MH, Ward S, Sherman G, Prentice D, Schaiff R, Huey W, Fraser VJ. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med 2000;28:3456-64.
22. Lawrence C, Tuma R, Guha S, Michael H, Lowy FD, Shuter J. Multiple antibiotic changes during the first 72 h of hospitalisation. Am J Med Sci 2001;322:61-7.
23. Thuong M, Shortgen F, Zazempa V, Girou E, Soussy CJ, BrunBuisson C. Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted reevaluation. J Antimicrob Chemother 2000;46:501-8.
24. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995;274:700-5.
25. Institute of Medicine. Committee on Clinical Practice Guidelines, Guidelines for clinical practice. From development to use. In: Field MJ, Lohr KN, editors. Washington, DC: National Academy Press; 1992.
26. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342:1317-22.
27. Woolf SH. Do clinical practice guidelines define good medical care ? The need for good science and the disclosure of uncertainty when defining "best practices". Chest 1998;113(Suppl 3):166-1671.
28. Gross PA. Practice guidelines for infectious diseases: Rationale for a Work in Progress. Clin Infect Dis 1998;26:1037-41.
29. NHS Centre for Reviews and Dissemination. Getting evidence into pratice. Effective Health Care 1999;5:1-16.
30. Gross PA. Implementing practice guidelines guidelines for appropriate antimicrobial use. A systematic review. Med Care 2001;39(Suppl 2):55-69.
31. Dean NC, Suchyta MR, Bateman KA, Aronsky DA, Hadlock CJ. Implementation of admission decision support for community -acquired pneumonia. A pilot study. Chest 2000;117:1368-77.
32. Fein AM, Niedermann MS. Guidelines for the initial management of community-acquired pneumonia: savory recipe or cookbook for disaster? Am J Crit Care Med 1995;152:1149-53.
33. Marras TK, Chan CK. Use of guidelines in treating community-acquired pneumonia. Chest 1998;113:1689-94.
34. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. JAMA 2000;283:749-55.
35. Nathwani D, Rubinstein E, Barlow G, Davey P. Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care? Clin Infect Dis 2001;32:728-41.
36. Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001;29:1109-15.
37. Price J, Ekleberry A, Grover A, Melendy S, Baddam K, McMahon J, et al. Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit. Crit Care Med 1999;27:2118-24.
38. Fridkin SK, Edwards JR, Pichette SC, Pryor ER, McGowan Jr JE, Tenover FC, et al. Determinants of vancomycin use in adult intensive care units in 41 United States Hospitals. Clin Infect Dis 1999;28:1119-25.
39. Seto WH, Ching TY, Kou M. Hospital antibiotic prescribing successfully modified by immediate concurrent feedback. Br J Pharmacol 1996;41:229-34.
40. Davey P, Nathwani D. Sequential antibiotic therapy: the right patient, the right time and the right outcome. J Infect 1998;37:37-44.
41. Sevinc F, Prins JM, Koopmans PP, Langendijk PN, Bossuyt PM, Dankert J, et al. Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital. J Antimicrob Chemother 1999;43:601-6.
42. Fowler VG, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommandations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998;27:478-86.
43. Cabana MD, Rand SC, Powe NR, Wu AW, Wilson MH, Abboud PAD, et al. Why don't physicians follow clinical pratice guidelines. A. framework for improvement. JAMA 1999;282:1458-65.
44. Bamberger DM, Dahl SL. Impact of voluntary versus enforced compliance of third generation cephalosporin use in a teaching hospital. Arch Intern Med 1992;152:554-7.
45. Woodward RS, Medoff G, Smith MD, Gray JL. Antibiotic costs saving from formulary restrictions and physician monitoring in a medical-school-affliated hospital. Am J Med 1987;83:817-23.
46. Loeb M, Simor AE, Landry L, McGeer A. Adherence to antibiotic guidelines for pneumonia in chronic-care facilities in Ontario. Clin Invest Med 2001;24:304-10.
47. Soumerai SB, Aborn J, Taylor WC, Wessels M, Maher D, Hawley SL. Improving choice of prescribed antibiotics through concurrent reminders in an educational order form. Med Care 1993;31:552-8.
48. McGowan Jr JE, Finland M. Usage of antibiotics in a general hospital: effect of requiring justification. J Infect Dis 1974;130:165-8.
49. Rapin M, Duval J, Le Gall JR, Soussy CJ, Lemaire F, Harari A. Les septicémies de surinfection en réanimation. Leur prévention par la restriction de l'antibiothérapie. Nouv Presse Med 1975;4:483-6.
50. Coleman RW, Rodondi LC, Kaubisch S, Granzlla NB, O'Hanley PD. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med 1991;90:439-44.
51. McGowan Jr JE. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994;15:478-83.
52. Quale J, Landman D, Saurina G, Atwood E, Di Tore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996;23:1020-5.
53. Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999;28:1062-6.
54. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial klebsiella. JAMA 1998;280:1233-7.
55. White AC, Atmar RL, Wilson J. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibility and clinical outcomes. Clin Infect Dis 1997;25:230-9.
56. Himmelberg CJ, Pleasants RA, Weber DJ, Kessler JM, Samsa GP, Spivey JM, et al. Use of antimicrobial drugs in adults before and after removal of a restriction policy. Am J Hosp Pharm 1991;48:1220-7.
57. Echols R, Kowalsky SF. The use of antibiotic order form for antibiotic utilization review: influence on physician prescribing patterns. J Infect Dis 1984;150:803-7.
58. Avorn J, Soumeraï SB, Taylor W, Wessels MR, Janousek J, Weiner M. Reduction of incorrect antibiotic dosing through a structured educational order form. Arch Intern Med 1988;148:1720-4.
59. Gerding DN, Larson TA, Hughes RA, Weiler M, Shanholtzer C, Peterson LR. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 1991;35:1284-90.
60. Blok WL, Gyssens IC, Hekster YA, Koopmans PP, Van der Meer JWM. Feasibility of an antibiotic order form. First experience in the department of internal medicine of a university hospital. Pharm World Sci 1996;18:137-41.
61. Frank MO, Batteiger BE, Sorrensen SJ, Hartsein AI, Carr JA, Mc Comb JS, et al. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Clin Perform Qual Health Care 1997;5:180-8.
62. Shojania KG, Yokoe D, Platt R, Fiskio J, Ma'luf N, Bates DW. Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial. J Am Med Inform Assoc 1998;5:554-62.
63. Gyssens IC, Blok WL, Van Den Broek PJ, Hekster YA, Van Der Meer JW. Implementation of an educational program and an antibiotic order form to optimize quality of antimicrobial drug use in a department of internal medicine. Eur J Clin Microbiol Infect Dis 1997;16:904-12.
64. Blanc P, Von Elm BE, Geissler A, Granier I, Boussuges A, Durand Gasselin J. Economic impact of a rational use of antibiotics in intensive care. Intensive Care Med 1999;25:1407-12.
65. Gyssens IC, Van Den Broek PJ, Kullberg BJ, Hekster YA, Van der Meer JW. Optimizing antimicrobial therapy. A method for antimicrobial drug use evaluation. J Antimicrob Chemother 1992;30:724-7.
66. Hirschman SZ, Meyers BR, Bradbury K, Mehl B, Gendelman S, Kimelblatt B. Use of antimicrobial agents in a university teaching hospital. Evolution of a comprehensive programm. Arch Intern Med 1988;148:2001-7.
67. Causse R, Chouaid C, Callaert S. Impact d'une approche multidisciplinaire pour la maîtrise de la prescription des antibiotiques dans un établissement hospitalier. Presse Med 1998;27:1371-5.
68. Kollef MH, Vlasnik J, Sharpless I, Pasque C, Murphy D, Fraser V. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Resp Crit Care Med 1997;156:1040-8.
69. Gruson D, Hilbert G, Vargas F, Valentino R, Bebear C, Allery A, et al. Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Am J Respir Crit Care Med 2000;162:837-43.
70. Raymond DP, Pelletier SJ, Crabtree TD, Leason TG, Hamm LL, Pruett TL, et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 2001;29:1101-8.
71. Moleski R, Andriole V. Role of the infectious disease specialist in containing costs of antibiotics in the hospital. Rev Infect Dis 1986;8:488-93.
72. Classen DC. Information management in infectious diseases: survival of the fittest. Clin Infect Dis 1994;19:902-9.
73. John Jr JF, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in hospital. Clin Infect Dis 1997;24:471-85.
74. Schlesinger Y, Paltiel O, Yinnon AM. Analysis and impact of infectious disease consultations in a general hospital. J Hosp Infect 1998;40:39-46.
75. Byl B, Clevenberg P, Jacobs F, et al. Impact of infectious diseases specialists and microbiological data on the appropriatness of antimicrobial therapy for bacteremia. Clin Infect Dis 1999;29:60-6.
76. Yinnon AM. Whiter infectious diseases consultations? Analysis of 14 005 consultations from a five-year period. Clin Infect Dis 2001;33:1661-7.
77. Nathwani D, Davey P, France AJ, Phillips G, Orange G, Parratt D. Impact of an infection consultation service for bacteraemia on clinical management and use of resources. QJM 1996;89:789-97.
78. Lemmen SW, Becker G, Frank U, Daschner FD. Influence of an infectious disease consulting service on quality and costs of antibiotic prescriptions in a university hospital. Scand J Infect Dis 2001;33:219-21.
79. Eron LJ, Passos S. Early discharge of infected patients through appropriate antibiotic use. Arch Intern Med 2001;161:61-5.
80. Fraser GL, Stogsdill P, Dickens JD, Wennberg DE, Smith RP, Prato BS. Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med 1997;157:1689-94.
81. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992;326:281-6.
82. Fox BC, Imrey PB, Voights MB, Scott N. Infectious disease consultation and microbiologic surveillance for intensive care unit trauma patients: a pilot study. Clin Infect Dis 2001;33:289-95.
83. Gomez J, Conde Cavero SJ, Hernandez Cardona JL. The influence of an infectious diseases consultant on the appropriateness of antibiotic treatment in a general hospital. J Antimicrob Chemother 1996;38:309-14.
84. Fluckiger U, Zimmerli W, Sax H, Frei R, Widmer AF. Clinical impact of an infectious disease service on the management of bloodstream infection. Eur J Clin Microbiol Infect Dis 2000;19:493-500.
85. Gums JG, Yancey Jr RW, Hamilton CA, Kubilis PS. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy 1999;19:1369-77.
86. Gross R, Morgan AS, Kinky D, Weiner M, Gibson GA, Fishman NO. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 2001;33:289-95.
87. Classen DC, Burke JP, Wenzel RP. Infectious diseases consultation: impact on outcomes for hospitalized patients and results of a preliminary study. Clin Infect Dis 1997;24:468-70.
88. Solomon DH, Van Houten L, Glynn RJ, Baden L, Curtis K, Schrager H, et al. Academic detailing to improve use of broadspectrum antibiotics at an academic medical center. Arch Intern Med 2001;161:1897-902.
89. Lipsky BA, Baker CA, Mc Donald LL, Suzuki NT. Improving the appropriateness of vancomycin use by sequential interventions. Am J Infect Control 1999;27:84-91.
90. Chentag JJ, Ballow CH, Fritz AL, Paladino JA, Williams JD, Cumbo TJ, et al. Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory. Diagn Microbiol Infect Dis 1993;16:255-64.
91. Pestotnik SL, Evans RS, Burke JP, Gardner RM, Classen DC. Therapeutic antibiotic monitoring: surveillance using a computerized expert system. Am J Med 1990;88:43-8.
92. Evans RS, Classen DC, Pestotnik SL, Lundsgaarde HP, Burke JP. Improving empiric antibiotic selection using computer decision support. Arch Intern Med 1994;154:878-84.
93. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996;124:884-90.
94. Evans RS, Pestotnik SL, Classen D, Clemmer TP, Weaver LK, Orme JF, et al. A computer-assisted management program for antibiotics and other anti-infective agents. N Engl J Med 1998;338:232-8.
95. Arnow P, Chamberlin W. Debugging computer assisted antibiotic prescribing. Lancet 1995;345:207-8.